Literature DB >> 11744412

Influence of graft ischemic time on outcomes following lung transplantation.

S M Fiser1, I L Kron, S M Long, A K Kaza, J A Kern, D C Cassada, D R Jones, M C Robbins, C G Tribble.   

Abstract

BACKGROUND: Reperfusion injury is the most common cause of early mortality following lung transplantation. Although cold graft ischemic time has been reported to influence this injury, some lung grafts with short ischemic times develop significant reperfusion injury, whereas other grafts with more prolonged ischemic times do not develop injury. Our hypothesis was that ischemic time did not significantly influence reperfusion injury or other outcomes following lung transplantation.
METHODS: Data on 136 patients who had lung transplantation over a 10 year period was used for analysis.
RESULTS: Cold graft ischemic time > or = 6 hours did not increase the risk of reperfusion injury, acute rejection, cytomegalovirus infection, bacterial or fungal pneumonia, bronchiolitis obliterans syndrome, 1-month mortality, 1-year mortality, or 5-year mortality compared with ischemic times of either < 4 hours or 4 to 6 hours. The incidence of reperfusion injury was at least 20% for each time group.
CONCLUSIONS: At least 20% of all patients will develop reperfusion injury regardless of cold graft ischemic time. Prolonged ischemic times up to 8 hours do not result in a significant increase in adverse short-term, intermediate, or long-term outcomes. Cautious extension of ischemic time beyond the current target of 4 to 6 hours may be warranted for geographic expansion of the donor lung pool.

Entities:  

Mesh:

Year:  2001        PMID: 11744412     DOI: 10.1016/s1053-2498(01)00355-2

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  13 in total

Review 1.  Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies.

Authors:  Andrew I R Scott; Linda D Sharples; Susan Stewart
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Lung Transplant Center Volume Ameliorates Adverse Influence of Prolonged Ischemic Time on Mortality.

Authors:  D Hayes; M G Hartwig; J D Tobias; D Tumin
Journal:  Am J Transplant       Date:  2016-07-13       Impact factor: 8.086

3.  Geographic distance between donor and recipient does not influence outcomes after lung transplantation.

Authors:  Sara A Hennessy; Tjasa Hranjec; Abbas Emaminia; Damien J Lapar; Benjamin D Kozower; Irving L Kron; David R Jones; Christine L Lau
Journal:  Ann Thorac Surg       Date:  2011-10-31       Impact factor: 4.330

Review 4.  Shear stress-related mechanosignaling with lung ischemia: lessons from basic research can inform lung transplantation.

Authors:  Shampa Chatterjee; Gary F Nieman; Jason D Christie; Aron B Fisher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-09-19       Impact factor: 5.464

Review 5.  Lung donor selection criteria.

Authors:  John Chaney; Yoshikazu Suzuki; Edward Cantu; Victor van Berkel
Journal:  J Thorac Dis       Date:  2014-08       Impact factor: 2.895

Review 6.  Oxidative and nitrosative stress during pulmonary ischemia-reperfusion injury: from the lab to the OR.

Authors:  Jan F Gielis; Paul A J Beckers; Jacco J Briedé; Paul Cos; Paul E Van Schil
Journal:  Ann Transl Med       Date:  2017-03

Review 7.  Historical perspectives of lung transplantation: connecting the dots.

Authors:  Tanmay S Panchabhai; Udit Chaddha; Kenneth R McCurry; Ross M Bremner; Atul C Mehta
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

8.  Bronchiolitis obliterans syndrome occurs earlier in the post-lung allocation score era.

Authors:  Abbas Emaminia; Sara A Hennessy; Tjasa Hranjec; Damien J LaPar; Benjamin D Kozower; David R Jones; Irving L Kron; Christine L Lau
Journal:  J Thorac Cardiovasc Surg       Date:  2011-02-12       Impact factor: 5.209

Review 9.  Overview of lung transplantation.

Authors:  Marlyn S Woo
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

10.  Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs.

Authors:  Raphael Briot; James A Frank; Tokujiro Uchida; Jae W Lee; Carolyn S Calfee; Michael A Matthay
Journal:  Chest       Date:  2008-11-18       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.